What is Kyverna Therapeutics, Inc.'s free cash flow yield?

Kyverna Therapeutics, Inc. (KYTX) reported free cash flow yield of -27.4% in Q4 2025.

How has Kyverna Therapeutics, Inc.'s free cash flow yield changed year-over-year?

Kyverna Therapeutics, Inc.'s free cash flow yield increased by 62.0% year-over-year, from -72.1% to -27.4%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Kyverna Therapeutics, Inc. KYTX Free cash flow yield

Free cash flow yield at other companies

Bristol-Myers SquibbBMY

9.6%-0.9pp

Gilead SciencesGILD

5.9%-1.1pp

Artiva Biotherapeutics, Inc.ARTV

-50.4%-14.3pp

Iovance Biotherapeutics, Inc.IOVA

-21.1%-5.3pp

Viridian Therapeutics, Inc.VRDN

-15.2%-4.4pp

Vor BiopharmaVOR

-17.3%-7.9pp

Other financials

Income statement

See full

Operating income-$41.4M+12.7%

Net income-$39.7M+11.0%

EPS (diluted)-$0.66+35.9%

Balance sheet

See full

Cash & equivalents$32.2M-43.4%

Total debt$9.2M+32.1%

Total equity$195.6M-12.7%

Total assets$257.0M-1.4%

Cash flow

See full

Operating cash flow-$41.6M+7.4%

CapEx$2.0K-98.0%

Free cash flow-$33.5M+10.8%

Valuation

See full

Market cap$498.52M+276%

Enterprise value$475.49M+475%

Returns & leverage

See full

Return on equity-74.5%+74.4pp

Debt / equity0×0.0×

Current ratio8.1×+0.7×

Where this comes from

Calculated from Kyverna Therapeutics, Inc.’s reported figures.

free cash flow/market cap=-27.4%

Based on trailing twelve months.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s free cash flow yield?: Kyverna Therapeutics, Inc. (KYTX) reported free cash flow yield of -27.4% in Q4 2025.
How has Kyverna Therapeutics, Inc.'s free cash flow yield changed year-over-year?: Kyverna Therapeutics, Inc.'s free cash flow yield increased by 62.0% year-over-year, from -72.1% to -27.4%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.